Wright Medical initiated at Stifel

Wright Medical initiated with a Buy at Stifel. Stifel analyst Mathew Blackman initiated Wright Medical with a Buy rating and $34 price target, citing its market share-leading positions in surgical repair of upper and lower extremities, which he identifies as two of the fastest-growing medical device industry end-markets. He sees sales growth sustainably accelerating back to low-double digits, Blackman tells investors.

https://bit.ly/2OS1dHA